Pharmacologic Prophylaxis for Acute Mountain Sickness: A Systematic Shortcut Review
- 1 April 2012
- journal article
- review article
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 59 (4) , 307-317.e1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prospective, Double-Blind, Randomized, Placebo-Controlled Comparison of Acetazolamide Versus Ibuprofen for Prophylaxis Against High Altitude Headache: The Headache Evaluation at Altitude Trial (HEAT)Wilderness & Environmental Medicine, 2010
- Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trialQJM: An International Journal of Medicine, 2009
- Gabapentin for prevention of hypobaric hypoxia-induced headache: Randomized double-blind clinical trialJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Sumatriptan for prevention of acute mountain sickness: randomized clinical trialAnnals of Neurology, 2007
- Acetazolamide 125 mg BD Is Not Significantly Different from 375 mg BD in the Prevention of Acute Mountain Sickness: The Prophylactic Acetazolamide Dosage Comparison for Efficacy (PACE) TrialHigh Altitude Medicine & Biology, 2006
- Prevention of Acute Mountain Sickness by Acetazolamide in Nepali Porters: A Double-Blind Controlled TrialWilderness & Environmental Medicine, 2006
- Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT)BMJ, 2004
- Magnesium for the prevention and treatment of acute mountain sicknessClinical Science, 2004
- High-Altitude IllnessNew England Journal of Medicine, 2001
- THE INCIDENCE, IMPORTANCE, AND PROPHYLAXIS OF ACUTE MOUNTAIN SICKNESSThe Lancet, 1976